The Health Care M&A Monthly: The Big Spenders Of 2010–

Healthcare

37 Buyers Spent $1.0 Billion Or More On Health Care M&A From years past, we have come to expect a lull in merger and acquisition activity from Thanksgiving through New Year’s Day. Instead of announcing new, large transactions, dealmakers typically use the holiday...

The Health Care M&A Monthly: Pfizer Rejoins The Fray–

Healthcare

Makes Three Deals Worth $4.2 Billion In One Month Since acquiring Wyeth last year for $68.0 billion, Pfizer (NYSE: PFE) has kept a relatively low acquisition profile, buying a biotech here, a generic pharma there, all for relatively small amounts. That changed this...

The Health Care M&A Monthly: Third Quarter M&A Results–

Healthcare

215 Deals Posted Worth $65.9 Billion Based on preliminary data, the health care industry posted a total of 215 mergers and acquisitions in the third quarter of 2010. A total of $65.9 billion was committed to fund this activity. Despite a lower level in deal volume,...

The Health Care M&A Monthly: JNJ Buys Crucell, NV–

Healthcare

Pays $2.4  Billion To Grow Vaccines Business Johnson & Johnson (NYSE: JNJ) recently announced plans to buy the remaining 82.1% that it does not already own of Crucell, NV (NASDAQ: CRXL), the Dutch vaccines company. The purchase price is $2.4 billion. This deal...